COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after […]
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage Read More »
More than 200,000 prescriptions for copies of Novo Nordisk’s (NYSE: NVO) weight-loss drug Wegovy are getting filled by U.S. patients
Exclusive: Thousands Turn to Wegovy Copies Each Month as FDA Considers Shortage Status Read More »
On Monday, Merck (NYSE: MRK) said its drug, Winrevair, helped significantly reduce the risk of death in patients with a
Merck’s Therapy for Rare Lung Condition Shown to Reduce Risk of Death in Study Read More »
Halozyme Therapeutics (NASDAQ: HALO) has pulled its proposal to buy Evotec SE (NASDAQ: EVO) for 2 billion euros ($2.09 billion)
Halozyme Withdraws $2.1 Billion Acquisition Bid for Evotec Read More »
Sanofi (NASDAQ: SNY), the French drugmaker, plans to change its policy on how it gives discounts to certain U.S. hospitals
Sanofi to Revise US Hospital Drug Discount Program, WSJ Reports Read More »
BRUSSELS/LONDON – Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S.
Novo Holdings Nears EU Approval for $16.5 Billion Catalent Acquisition: Source Read More »
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co (NYSE: MRK) may
Exclusive: US FDA Discovers Link Between Popular Asthma Drug and Mental Health Issues Read More »
Britain’s competition watchdog fined U.S. firm Viatris (NASDAQ: VTRS) 1.5 million pounds ($1.88 million) on Friday for violating an order
UK Watchdog Fines Viatris $1.9 Million Over Rule Breach in Theramex Probe Read More »
FRANKFURT – Novartis (NYSE: NVS) raised its medium-term sales guidance on Thursday to 6% annual growth through 2028, driven by
Novartis Raises Sales Guidance Until 2028 Read More »
Copyright © 2024 abbonews.com
